Search

everythinglearnresearchcommunity

for

Search:↓

The article explains how to tell apart and treat two common causes of hair loss in women.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

GSH-T levels in hair follicles are similar in smokers and non-smokers and don't increase with certain treatments.

Scalp cooling helps prevent hair loss during chemotherapy for breast cancer.

Tufted folliculitis is common in patients with folliculitis decalvans.

Female pattern hair loss is linked to genetics, family history, and lifestyle factors.

Adipose tissue changes in obesity can trigger stress in fat cells.

A rare, non-cancerous ovarian tumor was successfully treated with surgery, improving the patient's symptoms.

H. pylori infection may be linked to the hair shedding condition Telogen Effluvium.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.

COVID-19 patients with hair loss experienced greater cognitive deficits and more symptoms of depression, anxiety, and stress.

Iron chelators can effectively reduce hair loss and improve hair growth in autoimmune alopecia.

Treatment balancing hormones stopped hair loss in most women with androgenetic alopecia.

Stress worsens symptoms and body changes in women with PCOS, especially during COVID-19.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

CO2 laser-associated PDT effectively treated therapy-resistant folliculitis decalvans.

Frontal fibrosing alopecia is increasing, especially in postmenopausal women, and treatment with finasteride can improve it.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Trichoscopic features help diagnose and assess female pattern hair loss severity, with inflammation playing a key role.

Topical minoxidil can cause severe liver failure.

TSH levels are similar across nonscarring alopecia types, with unclear racial differences.

Trichotillomania incognita can mimic hair loss patterns and requires careful diagnosis to avoid misdiagnosis.

Low iron levels may be linked to hair loss in women with chronic telogen effluvium.

Low fluence photoepilation temporarily removes hair by targeting the hair follicle's pigmented area without severe damage.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Women with early onset androgenetic alopecia have worse lipid profiles.

Hormonal imbalances are important in the development of male pattern baldness.

Oophorectomy lowers testosterone and estrogen levels in both premenopausal and postmenopausal women, with postmenopausal women still producing significant testosterone.